Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 2875 of 3033 entries
View as:

A Study of Cerebral Perfusion with TDCS in Chronic Hypoperfusion

Phase: N/A Priority: Normal
NCT ID: NCT06477107 Org: User:
Start: 10/24/24 End: 06/30/26 Due: 06/30/27

Analysis of Biomarkers in Lymph Node Tissue

Phase: N/A Priority: Normal
NCT ID: NCT04228796 Org: User:
Start: 01/06/20 End: 01/31/27 Due: 01/31/28

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00830557 Org: User:
Start: 10/01/00 End: 12/30/25 Due: 12/30/26

Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging

Phase: N/A Priority: Normal
NCT ID: NCT01027767 Org: User:
Start: 05/31/09 End: 09/30/12 Due: 09/30/13

Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02874014 Org: User:
Start: 07/25/16 End: 04/30/25 Due: 04/30/26

E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT05388877 Org: User:
Start: 10/20/22 End: 12/31/26 Due: 12/31/27

Noninvasive Ultrasound Assessment of Detrusor Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT05652023 Org: User:
Start: 04/20/23 End: 12/20/28 Due: 12/20/29

Monogenic Kidney Stone - Genetic Testing

Phase: N/A Priority: Normal
NCT ID: NCT03305835 Org: User:
Start: 09/11/17 End: 02/29/28 Due: 02/28/29

Regional Lipolysis Insulin Regulation

Phase: N/A Priority: Normal
NCT ID: NCT06392854 Org: User:
Start: 05/01/24 End: 06/30/28 Due: 06/30/29

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Phase: N/A Priority: Normal
NCT ID: NCT05541016 Org: User:
Start: 02/21/23 End: 08/01/29 Due: 08/01/30

Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02069847 Org: User:
Start: 02/28/14 End: 01/11/19 Due: 01/11/20

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03942328 Org: User:
Start: 09/19/19 End: 02/29/28 Due: 02/28/29

Microbreaks in the OR to Mitigate High Physical and Mental Demands

Phase: N/A Priority: Normal
NCT ID: NCT02565394 Org: User:
Start: 01/02/15 End: 11/06/17 Due: 11/06/18

Automating Delirium Severity in the ICU

Phase: N/A Priority: Normal
NCT ID: NCT06172491 Org: User:
Start: 01/15/23 End: 12/18/26 Due: 12/18/27

A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients

Phase: N/A Priority: Normal
NCT ID: NCT03598829 Org: User:
Start: 07/01/18 End: 11/15/23 Due: 11/15/24

Behavioral Interventions to Prevent or Delay Dementia

Phase: N/A Priority: Normal
NCT ID: NCT02265757 Org: User:
Start: 06/30/14 End: 03/31/18 Due: 03/31/19

Eosinophils in Human Adipose Tissue

Phase: N/A Priority: Normal
NCT ID: NCT04898400 Org: User:
Start: 06/01/21 End: 12/31/25 Due: 12/31/26

Multicomponent Intervention to Decrease Chronic Obstructive Pulmonary Disease (COPD)-Related Hospitalizations

Phase: N/A Priority: Normal
NCT ID: NCT01058486 Org: User:
Start: 09/30/10 End: 07/31/16 Due: 07/31/17

Wearable Devices to Monitor Seizures in Autoimmune Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT05627661 Org: User:
Start: 10/27/22 End: 11/22/23 Due: 11/22/24

A Study to Evaluate White Matter Hyperintensities in Migraine

Phase: N/A Priority: Normal
NCT ID: NCT05112289 Org: User:
Start: 08/16/21 End: 08/31/25 Due: 08/31/26

Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT00943176 Org: User:
Start: 06/30/09 End: 04/30/11 Due: 04/30/12

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05730712 Org: User:
Start: 03/08/24 End: 10/31/27 Due: 10/31/28

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT00737191 Org: User:
Start: 08/31/08 End: 11/30/09 Due: 11/30/10

Trial Evaluating the Effect of Facilitated Small Group Sessions on Physician Well-Being, Job Satisfaction, and Professionalism

Phase: N/A Priority: Normal
NCT ID: NCT01159977 Org: User:
Start: 06/30/10 End: 06/30/12 Due: 06/30/13

Bladder Bank (a Prospective Banking Study)

Phase: N/A Priority: Normal
NCT ID: NCT06109857 Org: User:
Start: 07/06/22 End: 12/01/27 Due: 12/01/28